Patents by Inventor Wilfrid Dieryck

Wilfrid Dieryck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6916787
    Abstract: A method for producing haemin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of an animal haemin protein capable of reversibly binding oxygen, or for a variant or portion of said protein component, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the haemin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying a haemin protein that includes a complex consisting of the protein or proteins coded for by said nucleic acid and at least one iron-containing porphyritic nucleus, or a plurality of such complexes.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: July 12, 2005
    Assignees: Institut National de la Sante et de Recherche Medicale, Meristern Therapeutics
    Inventors: Bertrand Merot, Wilfrid Dieryck, Philippe Lenee, Michael Marden, Veronique Gruber, Renee-Josee Pagnier, Sylvie Baudino, Claude Poyart
  • Publication number: 20020194643
    Abstract: A method for producing haemin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of an animal haemin protein capable of reversibly binding oxygen, or for a variant or portion of said protein component, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the haemin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying a haemin protein that includes a complex consisting of the protein or proteins coded for by said nucleic acid and at least one iron-containing porphyritic nucleus, or a plurality of such complexes.
    Type: Application
    Filed: October 18, 2001
    Publication date: December 19, 2002
    Applicant: Meristern Therapeutics and Institut National de la Sante et de la Recherche Medicale
    Inventors: Bertrand Merot, Wilfrid Dieryck, Philippe Lenee, Michael Charles Marden, Veronique Gruber, Renee-Josee Pagnier, Sylvie Baudino, Claude Poyart
  • Patent number: 6344600
    Abstract: A method for producing human hemoglobin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of a human hemoglobin protein capable of reversibly binding oxygen, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the human hemoglobin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying the human hemoglobin protein that includes a complex consisting of the protein or proteins coded for by the nucleic acid and at least one iron-containing polphyritic nucleus, or a plurality of such complexes.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: February 5, 2002
    Assignees: Meristem Therapeutics, Institut National de la Sante et de la Recherche Medicale
    Inventors: Bertrand Merot, Wilfrid Dieryck, Philippe Lenee, Michael Marden, Veronique Gruber, Renee-Josee Pagnier, Sylvie Baudino, Claude Poyart